MENU
INDP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Indaptus Therapeutics (INDP) Earnings Date & Reports

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy... Show more

A.I. Advisor
published Earnings

INDP is expected to report earnings to fall 40.62% to -18 cents per share on August 18

Indaptus Therapeutics INDP Stock Earnings Reports
Q2'25
Est.
$-0.19
Q1'25
Missed
by $0.14
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.16
Q2'24
Beat
by $0.11
The last earnings report on May 14 showed earnings per share of -31 cents, missing the estimate of -18 cents. With 3.88K shares outstanding, the current market capitalization sits at 8.01M.
View a ticker or compare two or three
INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. INDP showed earnings on May 14, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
3 Columbus Circle
Phone
+1 646 427-2727
Employees
7
Web
https://www.indaptusrx.com